ASX vs PAYX

The Advanced Deterministic Scorecard shows a Piotroski F-Score of 6/9, indicating stable financial health, but the absence of an Altman Z-Score limits distress risk assessment. The stock trades at a high valuation (P/E 38.78, Price/Book 8.44) despite solid recent earnings growth and strong 5-year price performance. While profitability and growth metrics are favorable, weak technical trend and inconsistent earnings surprises raise caution. The Graham Number of $5.08 suggests significant overvaluation, though growth-based intrinsic value of $11.15 supports a higher fair value.

Paychex (PAYX) trades at a premium valuation with solid profitability and a compelling 3.85% dividend yield, but faces headwinds from near-term earnings contraction, elevated payout ratio, and negative insider activity. Despite strong historical ROE of 41.27% and gross margins above 70%, YoY earnings growth is negative (-10.2%), and price performance has significantly underperformed peers over 1Y (-20.7%) and 6M (-26.9%). The stock appears fairly valued relative to its growth trajectory when compared to sector peers like ROP and NXPI, though its P/E of 25.1x remains below the sector average of 126x. Analysts broadly concur with a 'hold' rating and a $134.29 target, implying ~20% upside, but weak recent insider sentiment and tight liquidity raise caution.